Patents by Inventor Ghaidaa KASHGARI

Ghaidaa KASHGARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
    Publication number: 20220339118
    Abstract: A bioactive suspension derived from freshly disaggregated tissue is provided, as well as related methods of formulation and use. The bioactive suspension may comprise a cell-free supernate derived from epidermal and dermal tissue that has been enzymatically and mechanically disaggregated, then separated, and which may contain tissue regeneration factors known to speed healing. The bioactive suspension may further comprise genetically-modified treatment cells, wild type cells, or both, and may be combined with one or more scaffolding elements to form a bioactive suspension combination product suitable for treatment of a cutaneous defect. Synthetic bioactive suspensions and bioactive suspension combination products are also provided.
    Type: Application
    Filed: April 22, 2022
    Publication date: October 27, 2022
    Inventors: Katie BUSH, Amelia Ruth HOPKIN, Briana Rachel LEE ALTMAN, Lauren Heard MANGUM, Kurinji PANDIYAN, Andrew Perry QUICK, Sohail JAHID, Ghaidaa KASHGARI
  • REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
    Publication number: 20220339254
    Abstract: A bioactive suspension derived from freshly disaggregated tissue is provided, as well as related methods of formulation and use. The bioactive suspension may comprise a cell-free supernate derived from epidermal and dermal tissue that has been enzymatically and mechanically disaggregated, then separated, and which may contain tissue regeneration factors known to speed healing. The bioactive suspension may further comprise genetically-modified treatment cells, wild type cells, or both, and may be combined with one or more scaffolding elements to form a bioactive suspension combination product suitable for treatment of a cutaneous defect. Synthetic bioactive suspensions and bioactive suspension combination products are also provided.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Inventors: Katie BUSH, Amelia Ruth HOPKIN, Briana Rachel LEE ALTMAN, Lauren Heard MANGUM, Kurinji PANDIYAN, Andrew Perry QUICK, Sohail JAHID, Ghaidaa KASHGARI
  • REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
    Publication number: 20220339202
    Abstract: A bioactive suspension derived from freshly disaggregated tissue is provided, as well as related methods of formulation and use. The bioactive suspension may comprise a cell-free supernate derived from epidermal and dermal tissue that has been enzymatically and mechanically disaggregated, then separated, and which may contain tissue regeneration factors known to speed healing. The bioactive suspension may further comprise genetically-modified treatment cells, wild type cells, or both, and may be combined with one or more scaffolding elements to form a bioactive suspension combination product suitable for treatment of a cutaneous defect. Synthetic bioactive suspensions and bioactive suspension combination products are also provided.
    Type: Application
    Filed: April 22, 2022
    Publication date: October 27, 2022
    Inventors: Katie BUSH, Amelia Ruth HOPKIN, Briana Rachel LEE ALTMAN, Lauren Heard MANGUM, Kurinji PANDIYAN, Andrew Perry QUICK, Sohail JAHID, Ghaidaa KASHGARI